The Association for Molecular Pathology and the Association of Pathology Chairs have voiced their support for the Verified Innovative Testing in American Laboratories (VITAL) Act of 2021.
Read More
Increased automation is needed more than ever to meet the ongoing demand for COVID-19 testing, particularly in small- and medium-size labs.
Read More
We are entering a pivotal moment in time in blood product inventory management. While optimizing blood supply inventory has always been a top priority, the COVID-19 pandemic has truly put blood banks to the test
Read More
Having genetic risk variants in the ABO gene might significantly increase the chances of developing COVID-19, and other genes may also increase COVID-19 risk, according to new research.
Read More
The partnership combines Ordrs’ technology platform that streamlines lab test authorization, purchasing, and access to results with Labalytics’ platform that provides testing workflow management, 50-state compliant testing reporting, and in-depth analytics for workforce screening and population management.
Read More